Microwave ablation devices market seen reaching $0.77 billion by 2030

The microwave ablation devices market is projected to grow from $0.52 billion in 2026 to $0.77 billion by 2030, according to The Business Research Company. Rising cancer cases, wider use of minimally invasive procedures and better imaging technology are driving demand, with North America leading now and Asia-Pacific expected to grow fastest.

Why it matters: - Microwave ablation devices are gaining traction because hospitals and cancer centers are seeking less invasive treatment options that can shorten recovery time and reduce damage to surrounding tissue. - The market’s projected rise to $0.77 billion by 2030 signals continued demand for tumor ablation technologies as cancer incidence grows worldwide.

What happened: - The Business Research Company said the microwave ablation devices market grew from $0.47 billion in 2025 to $0.52 billion in 2026. - The company projects the market will reach $0.77 billion by 2030, implying a 10.3% CAGR over the forecast period. - North America held the largest market share in 2025. - Asia-Pacific is expected to post the fastest growth through 2030. - The report covers Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East and Africa. - The company made a free sample report available here. - The full market report is available here.

The details: - Microwave ablation devices use high-frequency microwave energy to destroy diseased tissue through heat-induced coagulative necrosis. - The technology targets malignant or problematic cells while preserving surrounding healthy tissue. - The devices are minimally invasive and are associated with shorter operation times, less collateral tissue damage and faster recovery than traditional surgery. - Historical growth was driven by rising liver and lung cancer cases, greater use of radiofrequency ablation methods, limited access to advanced surgical interventions, progress in medical imaging and stronger hospital infrastructure in developed regions. - Future growth is expected to come from wider use of minimally invasive treatments, artificial intelligence, improved imaging, a larger elderly population, healthcare expansion in emerging markets and demand for shorter hospital stays. - The report identifies broader adoption of minimally invasive procedures, better thermal energy delivery, real-time imaging, outpatient treatment growth and device miniaturization as major trends. - The report also includes market attractiveness scoring, total addressable market analysis, company scoring matrix graphics and tables, Excel dashboards, market hotspots infographics and updated graphics and tables.

Between the lines: - The market outlook points to a broader shift in oncology toward procedures that can be done faster, with less trauma and more outpatient care. - The combination of aging populations, higher cancer incidence and better imaging support creates a long runway for ablation tools even before accounting for AI-driven upgrades. - North America’s lead suggests mature adoption, while Asia-Pacific’s faster growth points to where new demand is likely to build next.

What's next: - The market is expected to keep expanding as providers adopt more image-guided and outpatient ablation procedures. - Device makers are likely to focus on smaller systems, better precision and tools that integrate with real-time imaging and AI. - The cancer burden projected by the World Health Organization, including more than 35 million new cases by 2050, will remain a key demand driver.

The bottom line: - Microwave ablation devices are moving from a niche treatment tool to a broader cancer-care platform, with growth tied to the global shift toward minimally invasive procedures.